XROMI is indicated to reduce the frequency of painful crises and reduce the need for blood transfusions in pediatric patients aged 6 months of age and older with sickle cell anemia with recurrent moderate to severe painful crises.
From the U.S. FDA-approved label for Hydroxyurea (Hydroxycarbamide). Full label: DailyMed.
XROMI is indicated to reduce the frequency of painful crises and reduce the need for blood transfusions in pediatric patients aged 6 months of age and older with sickle cell anemia with recurrent moderate to severe painful crises.
From the U.S. FDA-approved label for Hydroxyurea (Hydroxycarbamide). Full label: DailyMed.
Initial dose: 15 mg/kg orally once daily. Monitor the patient’s blood count every two weeks. The dose may be increased by 5 mg/kg/day every 8 to 12 weeks until a maximum tolerated dose or 35 mg/kg/day is reached if blood counts are in an acceptable range.
Directions from the U.S. FDA-approved label for Hydroxyurea (Hydroxycarbamide) — your doctor or pharmacist may advise differently.
XROMI is contraindicated in patients: who have demonstrated a previous hypersensitivity to hydroxyurea or any other component of its formulation.. In patients who have demonstrated a previous hypersensitivity to hydroxyurea or any other component of its formulation.
Excerpt from the U.S. FDA-approved label for Hydroxyurea (Hydroxycarbamide). Talk to a pharmacist or doctor before use.
Hemolytic anemia: Monitor blood counts throughout treatment. If hemolysis persists, discontinue XROMI. Embryo-Fetal toxicity: Can cause fetal harm. Advise of potential risk to a fetus and use of effective contraception. Vasculitic toxicities: Institute treatment and discontinue XROMI if this occurs. Live Vaccinations: Avoid live vaccine use in a patient taking XROMI. Risks with concomitant use of antiretroviral drugs: Pancreatitis, hepatotoxicity, and neuropathy have occurred. Monitor for signs and symptoms in patients with HIV infection using antiretroviral drugs; discontinue XROMI and implement treatment.
Warnings and precautions excerpt from the U.S. FDA-approved label for Hydroxyurea (Hydroxycarbamide) — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described in detail in other labeling sections: Myelosuppression Hemolytic anemia Malignancies Vasculitic toxicities Live vaccinations Macrocytosis Pulmonary toxicity Most common adverse reactions (incidence > 5%) are neutropenia and thrombocytopenia, and popular rash. To report SUSPECTED ADVERSE REACTIONS, contact Rare Disease Therapeutics, Inc.
Excerpt from the U.S. FDA-approved label for Hydroxyurea (Hydroxycarbamide) — not a complete list. Talk to a pharmacist or doctor about side effects.
2 brands · 2 makers in the NepalDoc catalog — see the full Hydroxyurea (Hydroxycarbamide) guide →
16.2 Storage Store XROMI between 2°C to 8°C (35°F to 46°F) excursions permitted to 25°C (77°F) for up to 72 hours. Keep the bottle tightly closed to protect the integrity of the product and minimize the risk of accidental spillage. Do not freeze. Use within 12 weeks after initially opening the bottle. Discard unused XROMI remaining after 12 weeks of first opening the bottle.
Storage information from the U.S. FDA-approved label for Hydroxyurea (Hydroxycarbamide).
What is Cytodrox?
Cytodrox 500mg Capsule is a Hydroxyurea (Hydroxycarbamide) medicine made by Cipla Ltd. It comes as 500mg Capsule.
What is the generic name of Cytodrox?
The generic name of Cytodrox is Hydroxyurea (Hydroxycarbamide).
Which brands of Hydroxyurea (Hydroxycarbamide) are available in Nepal?
2 brands of Hydroxyurea (Hydroxycarbamide) are listed in the NepalDoc catalog, from 2 makers — including Hydab 500mg Capsule.
What are the side effects of Hydroxyurea (Hydroxycarbamide)?
The following clinically significant adverse reactions are described in detail in other labeling sections: Myelosuppression Hemolytic anemia Malignancies Vasculitic toxicities Live vaccinations Macrocytosis Pulmonary toxicity Most common adverse reactions (incidence > 5%) are neutropenia and thrombocytopenia, and popular rash.
What is the price of Cytodrox in Nepal?
NepalDoc does not list medicine prices. Prices are set by individual pharmacies in Nepal and change over time — this page confirms the brand sold in Nepal, its generic name, maker, strength and pack details so you can check the price at your pharmacy with confidence.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.